首頁 產業/市場分類 出版商一覽 Email 通知 GII媒體代理會議 公司簡介 聯絡我們
- English Japanese Korean
首頁 > 市場調查報告書 > 製藥 > 全球麻醉藥市場
產業/市場分類
製藥 (4816)
肥胖症治療 (44)
非專利藥 (129)
疫苗 (181)
神經疾病 (172)
骨頭疾病治療 (37)
動物用醫藥 (17)
處方藥 (156)
規章 (126)
感染疾病 (346)
精神病 (84)
製藥企業 (524)
糖尿病 (191)
癌症 (909)
藥物開發 (1449)
DDS (182)
OTC 非處方藥 (150)
市場調查報告書

全球麻醉藥市場

The World Anesthesia Drug Market

出版商 Kalorama Information
出版日期 2010年04月 商品編碼 117010
內容資訊 英文 180 pages
價格
US $ 3995 PDF by E-mail (Single User License)
US $ 4700 PDF by E-mail (Departmental Site License)
US $ 7990 PDF by E-mail (Global Site License)


全球麻醉藥市場 是由出版商Kalorama Information在2010年04月所出版的。 這份英文市場調查報告書包含180 pages 價格從美金3995起跳。

簡介

本報告書以全身麻醉、局部麻醉、補助療法3個領域為焦點,進行現在上市中的麻醉藥以及開發中的麻醉藥動向與收益預測,並有市場參入企業競爭動向,概述如下。

第1章 總綱

第2章 導論:全球麻醉藥市場

  • 導論語麻醉藥歷史
  • 麻醉藥種類
  • 投要路徑
  • 流通網
  • 人口統計動向

第3章 全身麻醉

  • 概要
  • 產品概要
  • 副廠藥的影響與入手性
  • 研究開發
  • 市場規模與成長
  • 競爭分析

第4章 局部麻醉

  • 概要
  • 產品概要
  • 副廠藥的影響與入手性
  • 研究開發
  • 市場規模與成長
  • 競爭分析

第5章 補助療法

  • 概要
  • 產品概要
  • 副廠藥的影響與入手性
  • 研究開發
  • 市場規模與成長
  • 競爭分析

第6章 麻醉藥:市場規模及預測

  • 市場規模及預測
  • 各產品麻醉藥市場
  • 各地區麻醉藥市場
  • 競爭分析

第7章 影響麻醉藥市場的課題與動向

  • 導論
  • 對麻醉藥的法規限制
  • 牙科與麻醉
  • 對兒童的麻醉藥與合併症
  • 麻醉藥的過敏反應
  • 麻醉藥對憂鬱症患者的好處
  • 麻醉藥與睡眠
  • 麻醉藥反應的性別差異
  • 意識下鎮靜動向
  • 麻醉藥的長期效果

第8章 企業簡介

  • 導論
  • Abbott Laboratories
  • AstraZeneca
  • Baxter International
  • Eisai
  • Endo Pharmaceuticals Holdings, Inc
  • Hospira, Inc
  • Merck/Schering-Plough
  • Roche

圖表

目錄

Abstract

This Kalorama Information report - The World Anesthesia Drug Market - focuses on three primary segments of anesthesia:

  • General Anesthesia
  • Local Anesthesia
  • Adjunctive Therapies in Anesthesia

The report covers both currently marketed and late stage development anesthesia drugs in detail. Revenues for each segment were generated using dollar and unit sales for each product. Forecasted figures were generated using a combination of projected surgical procedures, patent and exclusivity expirations, pricing trends, new developments and other factors.

The report includes statistical information for surgical procedures, incidence of conditions requiring surgery, and other relevant information. Statistical information is presented as a worldwide overview, with special emphasis on the U.S. The market segments provide an overview, description of products on the market, description of products in development, market estimates and forecasts, and competitive analysis of leading providers. The report also includes current issues and trends affecting the industry.

The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study Kalorama Information conducted interviews with more than 50 key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Specific interviews with pharmaceutical company representatives included marketing directors, division managers, and product representatives.

All market data pertains to the world market at the manufacturers' level. The base year for data was 2009. Historical data was provided for the years 2007 and 2008, with forecast data provided for 2010 through 2014. Compound annual growth rates (CAGRs) are provided for the 2007-2009, 2007-2014 and 2009-2014 periods for each industry segment covered. Competitive analysis is provided for the year 2009 with a projected competitive analysis for 2014. The forecasted market analysis for 2009-2014 was highly influenced by the probability of approval and sales of products in late stage development, product marketing, and demographic trends.

Table of Contents

CHAPTER ONE: EXECUTIVE SUMMARY

  • Introduction
  • Scope and Methodology
  • Size and Growth of the Market
  • Issues and Trends Affecting Market
  • Leading Competitors

CHAPTER TWO: INTRODUCTION: THE WORLD ANESTHESIA DRUG MARKET

  • Introduction and History to Anesthesia Drugs
  • Types of Anesthesia
    • General Anesthesia
    • Local Anesthesia
    • Adjunctive Therapies in Anesthesia
  • Routes of Administration
    • Inhalation
      • Mask Inhalation
      • Laryngeal Mask
      • Endotracheal Administration
      • Controlled Respiration
    • Intravenous
    • Topical Application
    • Transdermal/Transmucosal Application
  • Distribution Channels
  • Demographics and Statistics
  • Worldwide Demographics
  • Medical Procedures by Type
  • Complications in Anesthesia

CHAPTER THREE: GENERAL ANESTHESIA

  • Overview
    • Induction of General Anesthesia
      • Preoxygenation
      • Loss of Consciousness
  • Description of Products
    • Diprivan
    • Ultane/Sevorane
    • Lusedra
    • Precedex
    • Ethrane
    • Forane
    • Pentothal
    • Suprane
    • Ketalar
    • Brevital
  • Generic Drug Impact and Availability
  • Research and Development
    • Precedex
    • CNS 7056
    • AZD3043
  • Market Size and Growth
    • Total Market
    • Market by Delivery Method
    • Market by Geographical Region
  • Competitive Analysis

CHAPTER FOUR: LOCAL ANESTHESIA

  • Overview
    • Techniques of Administration
      • Topical Application
      • Transdermal/Transmucosal
      • Simple Local Infiltration
      • Regional Injections
    • Spinal and Epidural Anesthesia
      • Intrathecal Block
      • Epidural, Peridural Block
  • Description of Products
    • AminoAmides
      • Xylocaine/LidoSite/Lidoderm/Dentipatch
      • Zingo
      • Carbocaine/Isocaine/Polocaine
      • Marcaine/Sensorcaine
      • Citanest
      • Naropin
      • Septocaine
    • Amino Esters
      • Novocaine
      • Nesacaine
      • Cocaine Hydrochloride
    • Combinations
      • Synera/Pliaglis
      • EMLA
    • Generic Drug Impact and Availability
    • Research and Development
    • Market Size and Growth
      • Total Market
      • Market by Delivery Method
      • Market by Geographical Region
    • Competitive Analysis

CHAPTER FIVE: ADJUNCTIVE THERAPIES IN ANESTHESIA

  • Overview
  • Description of Products
    • Neuromuscular Blocking Agents
    • Preanesthetic Sedation and Anesthesia Maintenance
    • Anesthesia Reversal Agents
  • Generic Drug Impact and Availability
  • Research and Development
  • Market Size and Growth
    • Total Market
    • Market by Geographical Region
  • Competitive Analysis

CHAPTER SIX: ANESTHESIA DRUGS: TOTAL MARKET SIZE AND FORECAST

  • Total Market Size and Forecast
  • Anesthesia Market by Product Type
  • Anesthesia Market by Geographical Region
  • Competitor Analysis

CHAPTER SEVEN: ISSUES AND TRENDS AFFECTING THE ANESTHESIA DRUG MARKET

  • Introduction
  • Regulation of Anesthesia Drugs
  • Dentistry and Anesthesia
  • Anesthesia and Complications in Pediatric Applications
  • Allergic Reactions in Anesthesia
    • Recent Propofol Recall
  • Anesthesia and the Benefits to Depression Patients
  • Anesthesia and Sleep
  • Gender Differences in Anesthesia Reaction
  • Trends in Conscious Sedation
  • Long-term Effects of Anesthesia

CHAPTER EIGHT: CORPORATE PROFILES

  • Introduction
  • Abbott Laboratories
  • AstraZeneca
  • Baxter International
  • Eisai Co
  • Endo Pharmaceuticals Holdings, Inc
  • Hospira, Inc
  • Merck/Schering-Plough
  • Roche
  • List of Companies

LIST OF EXHIBITS

CHAPTER ONE: Executive Summary

  • Table 1-1: The Total World Market for Anesthesia Drugs 2007-2014
  • Figure 1-1: The Total Market for Anesthesia Drugs 2007-2014

CHAPTER TWO: Introduction The World Anesthesia Drug Market

  • Table 2-1: World Population by Selected Geographical Region, 2010-2050
  • Figure 2-1: World Population by Selected Geographical Region, 2010-2050
  • Table 2-2: Procedures by Type, Average Annually 2006-2009
  • Figure 2-2: Procedures by Type Worldwide, Average Annually 2006-2009
  • Figure 2-3: Procedures by Type U.S., Average Annually 2006-2009
  • Table 2-3: Worldwide Anesthesia Complications and Related Mortality
  • Figure 2-4: Worldwide Anesthesia Complications and Related Mortality

CHAPTER THREE: General Anesthesia

  • Table 3-1: Marketed Brands for General Anesthesia Drugs (Brand Name, Generic Name, and Manufacturer)
  • Table 3-2: Selected Generic Drug Manufacturers and Products for General Anesthesia
  • Table 3-1: Brand vs. Generic General Anesthetic Market 2007-2009
  • Table 3-3: General Anesthesia Drugs in Development
  • Table 3-4: The Market for General Anesthesia Drugs 2007-2014
  • Figure 3-2: The Market for General Anesthesia Drugs 2007-2014
  • Table 3-5: The Market for General Anesthesia Drugs Estimated Products Sales by Delivery Method, 2009
  • Figure 3-3: The Market for General Anesthesia Drugs Market Share by Delivery Method, 2009
  • Table 3-6: The Market for General Anesthesia Drugs Estimated Products Sales by Geographic Region, 2009
  • Figure 3-4: The Market for General Anesthesia Drugs Market Share by Geographic Region, 2009
  • Table 3-7: The Market for General Anesthesia Drugs Estimated Revenues and Market Share of Leading Suppliers 2007-2009
  • Figure 3-5: The Market for General Anesthesia Drugs Estimated Market Share by Leading Suppliers 2009

CHAPTER FOUR: Local Anesthesia

  • Table 4-1: Selected Marketed Local Anesthesia Drugs (Brand Name, Generic Name and Manufacturer)
  • Table 4-2: Selected Generic Drug Manufacturers and Products for Local Anesthesia
  • Table 4-1: Brand vs. Generic Local Anesthetic Market 2007-2009
  • Table 4-3: Local Anesthesia Drugs in Development
  • Table 4-4: The Market for Local Anesthesia Drugs 2004-2011
  • Figure 4-2: The Total Market for Local Anesthesia Drugs 2004-2011
  • Table 4-5: The Market for Local Anesthesia Drugs Estimated Products Sales by Delivery Method, 2009
  • Figure 4-3: The Market for Local Anesthesia Drugs Market Share by Delivery Method, 2009
  • Table 4-6: The Market for Local Anesthesia Drugs Estimated Products Sales by Geographic Region, 2009
  • Figure 4-4: The Market for Local Anesthesia Drugs Market Share by Geographic Region, 2009
  • Table 4-7: The Market for Local Anesthesia Drugs Estimated Revenues and Market Share of Leading Suppliers 2007-2009
  • Figure 4-5: The Market for Local Anesthesia Drugs Estimated Market Share by Leading Suppliers 2009

CHAPTER FIVE: Adjunctive Therapies in Anesthesia

  • Table 5-1: Selected Marketed Adjunctive Therapies in Anesthesia (Type, Brand Name, Generic Name, and Manufacturer)
  • Table 5-2: Selected Generic Drug Manufacturers and Products for Adjunctive Therapies in Anesthesia
  • Table 5-1: Brand vs. Generic Adjunctive Therapies in Anesthesia Market 2007-2009
  • Table 5-3: Adjunctive Therapies in Anesthesia in Development
  • Table 5-4: The Market for Adjunctive Therapies in Anesthesia 2007-2014
  • Figure 5-2: The Market for Adjunctive Therapies in Anesthesia 2007-2014
  • Table 5-5: The Market for Adjunctive Therapies in Anesthesia Estimated Products Sales by Geographic Region, 2009
  • Figure 5-3: The Market for Adjunctive Therapies in Anesthesia Market Share by Geographic Region, 2009
  • Table 5-6: The Market for Adjunctive Therapies in Anesthesia Estimated Revenues and Market Share of Leading Suppliers 2009
  • Figure 5-4: The Market for Adjunctive Therapies in Anesthesia Estimated Market Share by Leading Suppliers 2009

CHAPTER SIX: Anesthesia Drugs: Total Market Size and Forecast

  • Table 6-1: The Total World Market for Anesthesia Drugs 2007-2014
  • Figure 6-1: The Total Market for Anesthesia Drugs 2007-2014
  • Table 6-2: Anesthesia Drug Market by Type 2007-2014
  • Figure 6-2: Anesthesia Drug Market by Type 2007-2014
  • Figure 6-3: Anesthesia Drug Market by Type 2009
  • Figure 6-4: Anesthesia Drug Market by Type 2014
  • Table 6-3: Anesthesia Drug Market Estimated Products Sales by Geographic Region, 2009
  • Figure 6-5: Anesthesia Drug Market Market Share by Geographic Region, 2009 125
  • Table 6-4: Leading Suppliers Anesthesia Revenues and Significant Segments of Participation, 2009
  • Figure 6-6: Leading Suppliers - Anesthesia Revenues, 2009
Back to Top